Cipher Pharmaceuticals, Inc.

10.80

-0.1100-1.01%

Volume:396.00

Turnover:4.28K

Market Cap:273.67M

PE:16.14

High:10.80

Open:10.80

Low:10.80

Close:10.91

52wk High:12.50

52wk Low:6.63

Shares:25.34M

Float Shares:14.49M

Volume Ratio:0.06

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.6693

EPS(LYR):1.05

ROE:16.32%

ROA:5.30%

PB:2.40

PE(LYR):10.29

Loading ...

Overview Company News Filings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CPHRF/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CPHRF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CPHRF\",,,,,undefined,":{"symbol":"CPHRF","market":"US","secType":"STK","nameCN":"Cipher Pharmaceuticals, Inc.","latestPrice":10.8,"timestamp":1771448400000,"preClose":10.91,"halted":0,"volume":396,"delay":15,"changeRate":-0.010082493125572817,"floatShares":14493422,"shares":25340135,"eps":0.669272,"marketStatus":"Pre-Mkt","change":-0.11,"latestTime":"02-18 16:00:00 EST Delay","open":10.8,"high":10.8,"low":10.8,"amount":4284.8414,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.669272,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771511400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"OTCQX","adjPreClose":10.8,"volumeRatio":0.06466150649230182},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CPHRF\",,,,,undefined,":{"symbol":"CPHRF","floatShares":14493422,"roa":"5.30%","roe":"16.32%","lyrEps":1.049641,"volumeRatio":0.06466150649230182,"shares":25340135,"dividePrice":0,"high":10.8,"amplitude":0,"preClose":10.91,"low":10.8,"week52Low":6.63,"pbRate":"2.40","psRate":"5.47","week52High":12.5034,"institutionHeld":0,"latestPrice":10.8,"eps":0.669272,"divideRate":0,"volume":396,"delay":15,"ttmEps":0.669272,"open":10.8,"prevYearClose":10.98,"prevWeekClose":10.67,"prevMonthClose":10.681,"prevQuarterClose":10.98,"fiveDayClose":10.84,"twentyDayClose":10.88,"sixtyDayClose":9.6274},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CPHRF\",params:#limit:5,,,undefined,":[{"date":"2024-05-09","symbol":"CPHRF","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715284800000,"name":null,"time":"Post Market","dateTimestamp":1715227200000,"actualEps":null},{"market":"US","date":"2024-03-14","symbol":"CPHRF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710388800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-11-10","symbol":"CPHRF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1668056400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-03-17","symbol":"CPHRF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1647489600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-03-18","symbol":"CPHRF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1616040000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CPHRF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CPHRF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.75,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1759813200000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CPHRF\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2581539046","title":"Press Release: Cipher Pharmaceuticals Reports Third Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2581539046","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581539046?lang=en_us&edition=fundamental","pubTime":"2025-11-07 06:00","pubTimestamp":1762466400,"startTime":"0","endTime":"0","summary":"-- Adjusted EBITDA1 in Q3 2025 was $7.3 million, an increase of 79% over Q3. -- NatrobaTM sales were $8.1 million during the quarter, a sequential. -- Strong cash generation with $10.8 million cash from operations in Q3 2025. -- $12.0 million debt repayments and share repurchases of $1.6 million. -- Further de-levering with $5.0 million debt repayments post quarter end. MISSISSAUGA, ON, Nov. 6, 2025 /CNW/ - Cipher Pharmaceuticals Inc.    today announced its financial and operating results for the three and nine months ended September 30, 2025.-- Growth from the Canadian product portfolio of 5% in Q3 2025 and 18%. respectively, compared to $3.8 million and $10.8 million in Q3 2024 and. Ryan Mailling, CFO, commented: \"With the acquisition of the Natroba business closing only 15 months ago, we have made substantial progress towards de-levering the business and are very close to achieving a net-debt free position, with a total of $32 million in repayments on our revolving credit facility","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4555","BK4604","BK4585","BK4588","CPHRF","BK4099","TM","03160"],"gpt_icon":0},{"id":"2576172207","title":"Stifel Nicolaus Reaffirms Their Buy Rating on Cipher Pharmaceuticals (CPHRF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2576172207","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576172207?lang=en_us&edition=fundamental","pubTime":"2025-10-17 02:35","pubTimestamp":1760639716,"startTime":"0","endTime":"0","summary":"In a report released today, Justin Keywood from Stifel Nicolaus maintained a Buy rating on Cipher Pharmaceuticals, with a price target of C$20.00. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-cipher-pharmaceuticals-cphrf-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-cipher-pharmaceuticals-cphrf-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CPHRF","SF"],"gpt_icon":0},{"id":"2568958294","title":"Cipher Pharmaceuticals (CPHRF) Gets a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2568958294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568958294?lang=en_us&edition=fundamental","pubTime":"2025-09-17 19:56","pubTimestamp":1758110161,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Justin Keywood maintained a Buy rating on Cipher Pharmaceuticals yesterday and set a price target of C$20.00. The company’s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cipher-pharmaceuticals-cphrf-gets-a-buy-from-stifel-nicolaus-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cipher-pharmaceuticals-cphrf-gets-a-buy-from-stifel-nicolaus-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","CPHRF","BK4007","SF"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}